Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
144.27+1.01 (+0.71%)
At close: 04:00PM EDT
143.76 -0.51 (-0.36%)
After hours: 07:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close143.26
Open143.99
Bid143.71 x 800
Ask143.90 x 1300
Day's Range138.22 - 144.89
52 Week Range115.61 - 497.49
Volume8,451,142
Avg. Volume6,101,277
Market Cap57.385B
Beta (5Y Monthly)1.69
PE Ratio (TTM)4.24
EPS (TTM)34.02
Earnings DateAug 03, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est219.33
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
11% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MRNA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Moderna, Inc.
    Analyst Report: Moderna IncModerna Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious and cardiovascular diseases, rare diseases, immunological conditions, and cancer. The company has approximately 2,700 employees.
    Rating
    Fair Value
    Economic Moat
    16 days agoArgus Research
View more
Advertisement
Advertisement